YMAB - Y-mAbs Therapeutics, Inc.

QQQ $ 439.55 $ -0.26 (-0.06 %)

DIA $ 390.50 $ 1.74 (0.45 %)

SPY $ 517.10 $ 0.05 (0.01 %)

TLT $ 90.18 $ -0.55 (-0.61 %)

GLD $ 213.58 $ -0.63 (-0.29 %)

Previous Close

$ 13.61

Open

$ 15.44

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 12.94 - $ 15.50

52 Week Range

$ 4.60 - $ 20.90

Volume

1,593,136

Average Volume

Market Cap

595.84M

Beta (5Y Monthly)

$ 1.47

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2024	03-31-2024	10-Q
2	02-29-2024	12-31-2023	10-K
3	11-13-2023	09-30-2023	10-Q
4	08-10-2023	06-30-2023	10-Q
5	05-08-2023	03-31-2023	10-Q
6	03-30-2023	12-31-2022	10-K
7	11-07-2022	09-30-2022	10-Q
8	08-08-2022	06-30-2022	10-Q
9	05-09-2022	03-31-2022	10-Q
10	03-01-2022	12-31-2021	10-K
11	11-04-2021	09-30-2021	10-Q
12	08-09-2021	06-30-2021	10-Q
13	05-06-2021	03-31-2021	10-Q
14	03-01-2021	12-31-2020	10-K
15	11-05-2020	09-30-2020	10-Q
16	08-06-2020	06-30-2020	10-Q
17	05-07-2020	03-31-2020	10-Q
18	03-12-2020	12-31-2019	10-K
19	11-13-2019	09-30-2019	10-Q
20	08-14-2019	06-30-2019	10-Q
21	05-10-2019	03-31-2019	10-Q
22	03-22-2019	12-31-2018	10-K
23	11-13-2018	09-30-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Y-mAbs Reiterates Guidance
05/07/2024 21:56:28

2024 Financial GuidanceManagement reiterates its full year 2024 guidance:Anticipated total DANYELZA® net product revenues of be...

Y-mAbs Therapeutics Q1 2024 GAAP EPS $(0.1...
05/07/2024 21:43:33

Y-mAbs Therapeutics (NASDAQ:YMAB) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $...

Y-mAbs Therapeutics Announces Resignation ...
03/14/2024 13:06:43

Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (NASDAQ:YMAB), a commercial-stage biopharmaceutical compa...

Cracking The Code: Understanding Analyst R...
03/06/2024 14:00:24

HC Wainwright & Co. Maintains Buy on Y-mAb...
03/06/2024 11:48:16

HC Wainwright & Co. analyst Robert Burns maintains Y-mAbs Therapeutics (NASDAQ:YMAB) with a Buy and raises the price tar...

Canaccord Genuity Maintains Buy on Y-mAbs ...
03/04/2024 15:11:08

Canaccord Genuity analyst Bill Maughan maintains Y-mAbs Therapeutics (NASDAQ:YMAB) with a Buy and raises the price target fr...

BMO Capital Maintains Outperform on Y-mAbs...
03/04/2024 13:44:51

BMO Capital analyst Etzer Darout maintains Y-mAbs Therapeutics (NASDAQ:YMAB) with a Outperform and raises the price target f...

Why Zscaler Shares Are Trading Lower By 10...
03/01/2024 18:19:25

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

cooper-companies-reports-upbeat-results-joins-dell-netapp-tidewater-and-other-big-stocks-moving-higher-on-friday

Cooper Companies Reports Upbeat Results, J...
03/01/2024 16:18:21

U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday.

Why NetApp Shares Are Trading Higher By Ar...
03/01/2024 13:31:07

Shares of NetApp, Inc. (NASDAQ: NTAP) shares rose sharply in today’s pre-market trading after the company reported better-than...

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
03/01/2024 13:09:49

Y-mAbs Therapeutics Q4 2023 GAAP EPS $(0.0...
02/29/2024 21:56:52

Y-mAbs Therapeutics (NASDAQ:YMAB) reported quarterly losses of $(0.020) per share which beat the analyst consensus estimate of ...

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
02/29/2024 21:31:36

Earnings Scheduled For February 29, 2024
02/29/2024 10:15:24

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

Earnings Outlook For Y-mAbs Therapeutics
02/28/2024 18:02:03

HC Wainwright & Co. Maintains Buy on Y-mAb...
02/20/2024 12:33:04

HC Wainwright & Co. analyst Robert Burns maintains Y-mAbs Therapeutics (NASDAQ:YMAB) with a Buy and raises the price tar...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
01/15/2024 17:30:51

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
01/12/2024 17:31:08

HC Wainwright & Co. Reiterates Buy on Y-mA...
11/15/2023 12:21:12

HC Wainwright & Co. analyst Robert Burns reiterates Y-mAbs Therapeutics (NASDAQ:YMAB) with a Buy and maintains $11 price...

Y-mAbs Therapeutics Q3 EPS $(0.18) Beats $...
11/13/2023 22:34:13

Y-mAbs Therapeutics (NASDAQ:YMAB) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $...